Find latest CLL videos · 80+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
C

ASH 2024 Insights: GLOW Study 64-Month Follow-Up - 1L Ibrutinib + Venetoclax vs. Chlorambucil + Obinutuzumab in Elderly/Frail CLL

By 2024 ASH Annual Meeting Insights Hub FEATURING Carsten Utoft Niemann
By 2024 ASH Annual Meeting Insights Hub FEATURING Carsten Utoft Niemann
1 view
December 16, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

2024 ASH Annual Meeting Insights Hub: Leukemia Videos

05:20

New

ASH 2024 Insights: Zanubrutinib in Acalabrutinib-Intolerant Patients…

2024 ASH Annual Meeting Insights Hub

M. Shadman

08:17

New

ASH 2024 Insights: Ph3 CLL12 Trial - Impact of Ibrutinib on QoL in P…

2024 ASH Annual Meeting Insights Hub

E. Goergen

05:58

New

ASH 2024 Insights: Ibrutinib or Acalabrutinib in CLL - Impact of Dos…

2024 ASH Annual Meeting Insights Hub

M. Shadman

View All

Related Videos

21:28

New

Choosing BTKi or BCL2i or Combination Therapy for 1L CLL

Danielle Brander

308 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.6K views
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

350 views
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

842 views
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

502 views
15:17

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Nicole Lamanna

260 views
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

317 views
12:18

Debates in CLL: Continuous or Finite Duration Therapy

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Jain

159 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

912 views
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

454 views
18:29

Single vs. Multiple Agents in 2L Therapy for CLL

SOHO Brazil 2024

J. Burger

349 views
19:14

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and E…

2024 ASCO® Annual Meeting Insights Hub

K. Rogers, J. Woyach

309 views
14:13

New

Pirtobrutinib in CLL: Current and Potential Utility in the Treatment…

Nicole Lamanna

81 views
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

236 views
08:42

Venetoclax vs. BTKis in CLL Treatment

City of Hope

A. Danilov

254 views
14:22

Impact of Ibrutinib Dose Modifications in CLL

Ruemu Birhiray

293 views
15:26

New

Guideline-Based Treatment Approaches in CLL

Farrukh Awan

78 views
28:11

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Total Health

M. Rotta

240 views
19:29

Guidelines for Dose Reduction of Ibrutinib in CLL

Matthew McKinney

178 views
03:38

Managing Cardiotoxicities in TKI Therapy for CLL: Atrial Fibrillatio…

Avirup Guha

78 views
AUTOPLAY